Press Releases


Cardiome to Release Third Quarter Results

PRNewswire | 1 day 1 hour 41 minutes ago

NASDAQ: CRME TSX: COM... (more)


Hospira to Present at Piper Jaffray 21st Annual Health Care Conference Dec. 2

PRNewswire | 1 day 1 hour 42 minutes ago

... (more)


Microbix Biosystems Re-files Annual Results With OSC

PRNewswire | 1 day 3 hours 41 minutes ago

TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (the "Company") announces today that it has re-filed the Form 52-109F1 Certification of Annual Filings of William Gastle, the Chief Executive Officer and James Long, the Chief Financial Officer (the "Officer's Certificates") dated January 12, 2009 in connection with the annual audited financial statements for the year ended September 30, 2008.... (more)


Watson to Present at Credit Suisse Healthcare Conference

PRNewswire | 1 day 3 hours 41 minutes ago

... (more)


DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

PRNewswire | 1 day 4 hours 10 minutes ago

... (more)


Stull, Stull & Brody Announces Investigation on Behalf of Shareholders of Trimeris, Inc.

Business Wire | 1 day 4 hours 12 minutes ago

Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Trimeris, Inc. (“Trimeris” or the “Company”) (Nasdaq: TRMS) for possible breaches of fiduciary duty and other violations of state law in connection with an agreement by the Trimeris Board of Directors to sell all of the Company’s outstanding shares of common stock at a price of $3.60 per share to Arigene Co., Ltd. (“Arigene”).... (more)


Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution

PRNewswire | 1 day 9 hours 42 minutes ago

... (more)


Stellar Pharmaceuticals' Q3-2009 Financial Results Marked by Strong Growth and Continued Profitability

MarketWire | 1 day 9 hours 42 minutes ago

LONDON, ONTARIO -- (Marketwire) -- 11/06/09 -- Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCBB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced its financial results for the third quarter ended September 30, 2009. In this press release, unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been rounded to nearest hundred. ... (more)


Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting

PRNewswire | 1 day 10 hours 11 minutes ago

... (more)


Helix BioMedix Reports Third Quarter 2009 Financial Results

Business Wire | 1 day 10 hours 11 minutes ago

Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced financial results for the third quarter ended September 30, 2009.... (more)


Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results

PRNewswire | 1 day 11 hours 41 minutes ago

SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. ... (more)


GTC Biotherapeutics Reports Third Quarter 2009 Financial Results

Business Wire | 1 day 11 hours 41 minutes ago

GTC Biotherapeutics, Inc.’s ("GTC", NASDAQ: GTCB) total net loss for the third quarter ended September 27, 2009 was $5.1 million, or $0.48 per share, compared with $6.1 million, or $0.59 per share, in the third quarter of 2008. The total net loss for the first nine months of 2009 was $26.2 million, or $2.51 per share, compared to $16.5 million, or $1.71 per share, for the first nine months of 2008.... (more)




 1  2  3  4  5  6  7  8   Next >

108 Press Releases  |   RSS Feed



Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more

Latest Blog Postsview more


Companies in the news